Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1864 clinical trials
featured
Stage III Non-Small Cell Lung Cancer (NSCLC)

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

  • 15 views
  • 08 Jul, 2020
  • 1 location
featured
Metastatic Squamous or Non-Squamous Non-Small Cell Lung Cancer

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 4 views
  • 23 Nov, 2020
  • 1 location
featured
First- Line Metastatic Non-Small Cell Lung Cancer (NSCLC) MAGELLAN

People with metastatic non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 35 views
  • 27 Jun, 2019
  • 1 location
featured
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

recurrent non-small cell lung cancer
lung cancer
advanced lung cancer
refractory non-small cell lung cancer
lung metastases
  • 0 views
  • 18 Feb, 2021
  • 4 locations
featured
An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

cancer chemotherapy
adjuvant chemotherapy
EGFR
kinase inhibitor
cancer
  • 358 views
  • 08 Dec, 2020
  • 4 locations
featured
EpicentRx RRx001-211-01: RRx-001 in Patients with Small Cell Lung Cancer, High-grade Neuroendocrine Carcinoma, EGFR Mutation Positive Non-Small Cell Lung Cancer or Ovarian Cancer (Including Malignant Mixed Mullerian Tumore (MMMT) of the Ovary or Uterus) Previously Treated with a Platinum-based Regimen (QUADRUPLE THREAT)

EpicentRx RRx001-211-01: RRx-001 in Patients with Small Cell Lung Cancer, High-grade Neuroendocrine Carcinoma, EGFR Mutation Positive Non-Small Cell Lung Cancer or Ovarian Cancer (Including

EGFR
cancer
carcinoma
neuroendocrine carcinoma
small cell carcinoma
  • 786 views
  • 24 Nov, 2020
  • 1 location
featured
  • 12 views
  • 14 Dec, 2020
  • 1 location
featured
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Screening Step) Lung-MAP Study

A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Screening Step) Lung-MAP Study

lung cancer
lung carcinoma
cancer
  • 28 views
  • 23 Nov, 2020
  • 1 location
featured
LUX-Lung IO: A phase II, open label, non-randomised study of afatinib in combination with pembrolizumab in patients with locally advanced or metastatic squamous cell carcinoma of the lung

LUX-Lung IO: A phase II, open label, non-randomised study of afatinib in combination with pembrolizumab in patients with locally advanced or metastatic squamous cell carcinoma of the lung

lung carcinoma
chemotherapy regimen
cancer
alopecia
metastatic squamous cell carcinoma
  • 538 views
  • 24 Nov, 2020
  • 1 location
featured
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

  • 342 views
  • 08 Nov, 2020
  • 38 locations